Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€3.68

€3.68

2.220%
0.08
2.220%
€5.00
 
12:36 / Tradegate WKN: A0JJT3 / Symbol: VNDA / Name: Vanda Pharma / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Vanda Pharmaceuticals Stock

Vanda Pharmaceuticals gained 2.220% today.
The community is currently still undecided about Vanda Pharmaceuticals with 2 Buy predictions and 0 Sell predictions.
As a result the target price of 5 € shows a positive potential of 35.87% compared to the current price of 3.68 € for Vanda Pharmaceuticals.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Vanda Pharmaceuticals stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Vanda Pharmaceuticals in the next few years

Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Vanda Pharmaceuticals vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Vanda Pharmaceuticals 2.220% 3.468% -15.166% -43.622% -7.732% -72.672% -
Salarius Pharmaceuticals Inc. 1.470% -21.538% -20.000% -76.920% -26.486% -98.684% -99.992%
Ardelyx Inc. -0.870% -3.641% -22.870% 71.742% 19.031% 28.024% -
Evolus Inc 1.560% 1.563% -2.985% 66.667% 39.037% 31.287% -

Comments

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for VNDA provided by MarketBeat
Show more

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for VNDA provided by MarketBeat
Show more